Skip to main content
Fig. 4 | Respiratory Research

Fig. 4

From: Assessing the healthcare resource use associated with inappropriate prescribing of inhaled corticosteroids for people with chronic obstructive pulmonary disease (COPD) in GOLD groups A or B: an observational study using the Clinical Practice Research Datalink (CPRD)

Fig. 4

Rate ratios for subgroup analyses. a Patients with one previous exacerbation. b Patients with an eosinophil level >  0.3 × 109/L. c Patients with FEV1 <  50% predicted. HCP, healthcare practitioner; GP, General Practitioner; RR, respiratory-related; RRR, routine respiratory-related; SABA, short-acting β2 agonist; SAMA, short-acting muscarinic agonist; URR, unplanned respiratory-related

Back to article page